India, with its diverse climatic conditions and high population density, is a hotbed for vector-borne diseases (VBDs). These diseases, transmitted through insects such as mosquitoes, ticks, and fleas, pose a significant public health challenge, affecting millions annually.
India's VBDs landscape is dominated by malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for 88% of the Southeast Asia's burden. Dengue, with its rapid urban spread, has seen a 300% increase in the last five years. Chikungunya, though less lethal, causes debilitating joint pains affecting productivity. Japanese encephalitis, though region-specific, has a high mortality rate.
Multiple factors contribute to the VBD burden in India. Rapid urbanization and inadequate sanitation lead to breeding grounds for vectors. Climate change exacerbates the situation by expanding the vectors' geographical range. Additionally, the lack of public awareness and insufficient healthcare infrastructure hinder disease control efforts.
India's National Vector Borne Disease Control Programme (NVBDCP) is the central nodal agency for prevention and control of VBDs. Its strategies include early case detection, prompt treatment, integrated vector management, and public awareness campaigns. However, these strategies need strengthening through better implementation and regular monitoring.
Healthcare professionals play a crucial role in managing VBDs. Their tasks include early diagnosis, appropriate treatment, and patient education. Additionally, they can contribute to research for better diagnostic tools and treatments. Their role in policy advocacy for improved healthcare infrastructure and sanitation is equally important.
Vector-borne diseases remain a significant health challenge in India. A multifaceted approach involving improved sanitation, public awareness, robust healthcare infrastructure, and active involvement of healthcare professionals is necessary to alleviate this burden. Ongoing research and policy changes are essential to pave the way for a healthier India.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation